Collaborators of the NEtwork for Drug Quality and Safety (NEDQAS): Alaa F Alwan 2, Houria Boukhelal 3, Zoubir Chouffai 4, Fadi Farhat 5, Mahmoud Hadipour 6, Emad Hamada 7, Mohamed Kadhim Jaffar 8, Mehran Karimi 9, Fawaz Al-Kasim 10, Hayder H Al-Momen 11, Ahmad M Tarawah 12, Atholl Johnston 13, Khaled M Musallam 14
1Clinical Hematology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: firstname.lastname@example.org.
2National Center of Hematology and University College of Medicine, Baghdad, Iraq.
3University Hospital CHU Mustapha, Algiers, Algeria.
4Pediatric Oncology & Hematology Center, Casablanca, Morocco.
5Hammoud Hospital, Sidon, Lebanon.
6Iranian Thalassemia Society, Iran.
7Cairo University, Cairo, Egypt.
8Iraqi CML Patient Organization, Iraq.
9Hematology Research Center, Nemazee Hospital, Shiraz, Iran.
10King Saud Medical City, Riyadh, Saudi Arabia.
11Al-Kindy College of Medicine, Baghdad University, Baghdad, Iraq.
12Madinah Blood Disorders Center, King Abdullah Medical City, Madinah, Saudi Arabia.
13Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
14International Network of Hematology, London, UK.
No abstract available
Keywords: Copy drugs; Hematology; Middle east; Substandard medicines.